JPS51148013A - Stable insulin preparation for nosal administration - Google Patents

Stable insulin preparation for nosal administration

Info

Publication number
JPS51148013A
JPS51148013A JP5493176A JP5493176A JPS51148013A JP S51148013 A JPS51148013 A JP S51148013A JP 5493176 A JP5493176 A JP 5493176A JP 5493176 A JP5493176 A JP 5493176A JP S51148013 A JPS51148013 A JP S51148013A
Authority
JP
Japan
Prior art keywords
nosal
administration
insulin preparation
stable insulin
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5493176A
Other languages
English (en)
Japanese (ja)
Inventor
Shinichiro Hirai
Toshiaki Ikenaga
Etsu Matsuzawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of JPS51148013A publication Critical patent/JPS51148013A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP5493176A 1975-06-13 1976-05-13 Stable insulin preparation for nosal administration Pending JPS51148013A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2535175A GB1554157A (en) 1975-06-13 1975-06-13 Stable insulin preparation for intra nasal administration

Publications (1)

Publication Number Publication Date
JPS51148013A true JPS51148013A (en) 1976-12-18

Family

ID=10226264

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5493176A Pending JPS51148013A (en) 1975-06-13 1976-05-13 Stable insulin preparation for nosal administration

Country Status (5)

Country Link
JP (1) JPS51148013A (enrdf_load_stackoverflow)
BE (1) BE841870A (enrdf_load_stackoverflow)
DE (1) DE2620483A1 (enrdf_load_stackoverflow)
FR (1) FR2313914A1 (enrdf_load_stackoverflow)
GB (1) GB1554157A (enrdf_load_stackoverflow)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005532365A (ja) * 2002-06-18 2005-10-27 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 改善された安定性を有する酸性インスリン調製物
JP2007077151A (ja) * 2005-09-12 2007-03-29 Mcneil Ppc Inc 噴霧可能な個人用潤滑剤
JP2009292820A (ja) * 2003-12-08 2009-12-17 Cpex Pharmaceuticals Inc インスリン治療のための薬学的組成物及びその供給装置
JP2016530930A (ja) * 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783441A (en) * 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
DE3064888D1 (en) * 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
DE2917535C2 (de) * 1979-04-30 1986-10-30 Hoechst Ag, 6230 Frankfurt Gegen Denaturierung beständige Insulinlösungen
WO1983000288A1 (en) * 1981-07-17 1983-02-03 Balschmidt, Per A stable aqueous, therapeutic insulin preparation and a process for preparing it
DE3443877A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
CA1274774A (en) * 1985-04-15 1990-10-02 Kenneth S. Su Method for administering insulin
DK179286D0 (da) * 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
ES2045276T3 (es) * 1988-07-21 1994-01-16 Hoffmann La Roche Preparacion de insulina
ATE164080T1 (de) * 1990-05-10 1998-04-15 Bechgaard Int Res Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
CZ288146B6 (en) 1994-12-22 2001-05-16 Astra Ab Pharmaceutical aerosol preparation, process of its preparation and use
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
AU2009305472B2 (en) 2008-10-17 2013-12-19 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a GLP-1 agonist
RU2537239C2 (ru) 2009-11-13 2014-12-27 Санофи-Авентис Дойчланд Гмбх Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин
KR101772372B1 (ko) 2009-11-13 2017-08-29 사노피-아벤티스 도이칠란트 게엠베하 Glp-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
BR112013004756B1 (pt) 2010-08-30 2020-04-28 Sanofi Aventis Deutschland uso de ave0010 para a fabricação de um medicamento para o tratamento da diabetes melito tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
ITRM20110390A1 (it) 2011-07-21 2013-01-22 Eramo Alessandra D Prodotto per stimolare la produzione endogena di mediatori dell'infiammazione.
SI2750699T1 (sl) 2011-08-29 2015-11-30 Sanofi-Aventis Deutschland Gmbh Farmacevtska kombinacija, za uporabo pri glikemični kontroli pri pacientih, ki imajo sladkorno bolezen tipa 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
BR112017012406A2 (pt) 2014-12-12 2018-07-31 Sanofi Aventis Deutschland formulação com relação fixa de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL62232C (enrdf_load_stackoverflow) * 1900-01-01
US3096249A (en) * 1960-05-10 1963-07-02 Samuel J Prigal Emulsion composition

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005532365A (ja) * 2002-06-18 2005-10-27 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 改善された安定性を有する酸性インスリン調製物
JP2011006492A (ja) * 2002-06-18 2011-01-13 Sanofi-Aventis Deutschland Gmbh 改善された安定性を有する酸性インスリン調製物
JP2009292820A (ja) * 2003-12-08 2009-12-17 Cpex Pharmaceuticals Inc インスリン治療のための薬学的組成物及びその供給装置
JP2007077151A (ja) * 2005-09-12 2007-03-29 Mcneil Ppc Inc 噴霧可能な個人用潤滑剤
JP2016530930A (ja) * 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法

Also Published As

Publication number Publication date
DE2620483A1 (de) 1976-12-23
FR2313914B1 (enrdf_load_stackoverflow) 1979-04-13
FR2313914A1 (fr) 1977-01-07
GB1554157A (en) 1979-10-17
BE841870A (fr) 1976-11-16

Similar Documents

Publication Publication Date Title
JPS51148013A (en) Stable insulin preparation for nosal administration
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
JPS542316A (en) Solid pharmaceutical composition containing nifedipene
JPS52139713A (en) Sustained release cefalexin preparations
JPS539739A (en) #-trifluoromethyl-##-isoproxybenzoic acid anilide, its preparation and its use
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
JPS51125746A (en) Acyclohexane dione herbicide composition
JPS5366420A (en) Insecticide against maggots
JPS5318529A (en) Optically active mandelic acid phenylglycinol salt and its preparation
JPS5340779A (en) Optically active tolpertisone, their preparation and pharmaceuticals containting the same
JPS52151716A (en) Stabilization of mitomycin c
JPS5234921A (en) Fungicidal composition
JPS52139789A (en) Method of preparing stable powder of neocarzinostatin
JPS52148699A (en) Preparation of low salt soy
JPS5430185A (en) Mandelic acid derivative and carcinostatic agnet containing the same
JPS5279090A (en) Preparation of powdered soy sauce
JPS5312417A (en) Preparation of amorphous d rugs
JPS52144656A (en) N-(diphenylphosphonomethyl)-imino-diacetonitrile and its preparation
JPS51132255A (en) Resin solution composition
JPS51136818A (en) Method for preparing stable prostaglandine pharma ceuticals
JPS537686A (en) 6-oxo-2-piperzinylacetic acid and its preparation
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
JPS5261240A (en) Lipstick composition
JPS5231826A (en) Miticides
JPS5283603A (en) N2-substituted-omega-amidino-alpha-amino acid derivative and acid addition salt thereof